CL2017000601A1 - Macrocyclic inhibitors of protein / protein programmed death interactions 1 (pd-1) / pd-l1 and cd80 (b7-1) / pd-l1 - Google Patents

Macrocyclic inhibitors of protein / protein programmed death interactions 1 (pd-1) / pd-l1 and cd80 (b7-1) / pd-l1

Info

Publication number
CL2017000601A1
CL2017000601A1 CL2017000601A CL2017000601A CL2017000601A1 CL 2017000601 A1 CL2017000601 A1 CL 2017000601A1 CL 2017000601 A CL2017000601 A CL 2017000601A CL 2017000601 A CL2017000601 A CL 2017000601A CL 2017000601 A1 CL2017000601 A1 CL 2017000601A1
Authority
CL
Chile
Prior art keywords
protein
interactions
programmed death
macrocyclic inhibitors
macrocyclic
Prior art date
Application number
CL2017000601A
Other languages
Spanish (es)
Inventor
Qian Zhao
Paul Michael Scola
Eric P Gillis
Michael S Bowsher
Michael Matthew Miller
Claudio Mapelli
Martin Patrick Allen
David R Langley
Nishith Sanghvi
Kap Sun Yeung
Juliang Zhu
Eric Mukll
Maude A Poirier
Li Quiang Sun
Daniel J Tenney
Kevin W Gillman
Young Katharine A Grant
Lyndon A M Cornelius
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=61147231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2017000601(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to CL2017000601A priority Critical patent/CL2017000601A1/en
Publication of CL2017000601A1 publication Critical patent/CL2017000601A1/en

Links

Abstract

<p>LA PRESENTE DESCRIPCIÓN PROPORCIONA PÉPTIDOS MACROCÍCLICOS NOVEDOSOS QUE INHIBEN LAS INTERACCIONES PROTEÍNA/PROTEÍNA PPD-1/PD-L1 Y PD-L1/CD80, Y POR ENDE, SON ÚTILES PARA LA MEJORA DE VARIAS ENFERMEDADES, QUE INCLUYEN EL CÁNCER Y LAS ENFERMEDADES INFECCIOSAS.</p><p> THIS DESCRIPTION PROVIDES NOVELTY MACROCYCLIC PEPTIDES THAT INHIBIT THE PROTEIN / PROTEIN INTERACTIONS PPD-1 / PD-L1 AND PD-L1 / CD80, AND THEREFORE, ARE USEFUL FOR THE IMPROVEMENT OF VARIOUS DISEASES, WHICH INCLUDE AND C INFECTIOUS DISEASES. </p>

CL2017000601A 2017-03-10 2017-03-10 Macrocyclic inhibitors of protein / protein programmed death interactions 1 (pd-1) / pd-l1 and cd80 (b7-1) / pd-l1 CL2017000601A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2017000601A CL2017000601A1 (en) 2017-03-10 2017-03-10 Macrocyclic inhibitors of protein / protein programmed death interactions 1 (pd-1) / pd-l1 and cd80 (b7-1) / pd-l1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2017000601A CL2017000601A1 (en) 2017-03-10 2017-03-10 Macrocyclic inhibitors of protein / protein programmed death interactions 1 (pd-1) / pd-l1 and cd80 (b7-1) / pd-l1

Publications (1)

Publication Number Publication Date
CL2017000601A1 true CL2017000601A1 (en) 2017-11-17

Family

ID=61147231

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017000601A CL2017000601A1 (en) 2017-03-10 2017-03-10 Macrocyclic inhibitors of protein / protein programmed death interactions 1 (pd-1) / pd-l1 and cd80 (b7-1) / pd-l1

Country Status (1)

Country Link
CL (1) CL2017000601A1 (en)

Similar Documents

Publication Publication Date Title
CO2017003077A2 (en) Macrocyclic inhibitors of programmed death protein / protein 1 (pd-1) / pd-l1 and cd80 (b7-1) / pd-l1 interactions
UY37194A (en) IMMUNOMODULATORS
CL2017000855A1 (en) Immunomodulators
CO2018010316A2 (en) Immunomodulators
AR105053A1 (en) IMMUNOMODULATORS
UY35448A (en) MACROCYCLIC INHIBITORS OF PROTEIN / PROTEIN INTERACTIONS PD-1 / PD-L1 AND CD80 (B7-1) / PD-L1
UY36400A (en) MACROCYCLIC PEPTIDES AS INHIBITORS OF INTERACTIONS BETWEEN PD-1 / PD-L1 AND CD80 / PD-L1 PROTEINS AND THEIR IMMUNOMODULATORY FUNCTIONS
CL2019001328A1 (en) Chimeric insecticidal proteins, compositions that comprise them, and strategies for the control of lepidopteran pests based on their use.
BR112017019591A2 (en) immunomodulars
BR112017012704A2 (en) immunomodulators
CO2019007839A2 (en) Compositions and methods for inhibiting the action of arginase
CL2017001204A1 (en) 6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors
UY36950A (en) USEFUL COMPOUNDS AS INHIBITORS OF PROTEIN-PROTEIN INTERACTION PD-1 / PD-L1 AND CD80 / PD-L1 AND COMPOSITIONS CONTAINING THEM
MX2016013028A (en) Compounds useful as immunomodulators.
MX2017007677A (en) Immunomodulators.
CO2018008846A2 (en) Carboxamide derivatives useful as rsk inhibitors
CL2019002605A1 (en) Formulations containing pd-1 binding proteins and methods of manufacturing the same.
UY35733A (en) MACROCYCLIC INHIBITORS OF PROTEIN / PROTEIN INTERACTIONS PD-1 / PD-L1 AND CD80 (B7-1) / PD-L1 I.P.C.
CL2017000601A1 (en) Macrocyclic inhibitors of protein / protein programmed death interactions 1 (pd-1) / pd-l1 and cd80 (b7-1) / pd-l1
AR095488A1 (en) MACROCYCLIC INHIBITORS OF PROTEIN / PROTEIN INTERACTIONS PD-1 / PD-L1 AND CD80 (B7-1) / PD-L1
AR097659A1 (en) MACROCYCLIC INHIBITORS OF THE INTERACTIONS: PROTEIN OF THE SCHEDULED DEATH (PD-1) WITH ITS BIDDING (PD-L1) [INTERACTION PD-1 / PD-L1] AND OF THE DIFFERENTIATION Cumulus 80 (CD80) ALSO KNOWN AS PROTEIN B7-1 WITH LINK 1 OF THE PROGRAMMED DEATH PROTEIN (PD-L1) [CD80 OR B7-1 / PD-L1 INTERACTION]
UA109521C2 (en) SIMULATOR OF TOXIC SUBSTANCES (G-GAS GROUP) FOR TESTING DEGACY RECIPES
TH174558B (en) Macrocyclic inhibitors of protein / protein interactions PD-1 / PD-L1 and CD80 (B7-1) / PD-L1.